Mounjaro is one of the many GLP-1 medications currently available, specifically to people who have a Type 2 Diabetes diagnosis
When the medication is stopped or dose-adjusted, those hunger signals can return, making habit maintenance critical
These effects reduce caloric intake and improve glycaemic control mechanisms already validated in approved medicines such as semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda)
Some can even disqualify you for treatment. For example, you may not be able to take Semaglutide or Compounded Semaglutide if you have:' Hypersensitivity reactions to Semaglutide or any of its components Thyroid cancer Endocrine syndromes Other conditions, such as diabetic retinopathy or kidney impairment, may not completely disqualify you for treatment
If you do not tolerate the active ingredient of our active substances, you do not have to continue
c k thnh phn trnh nguy him khi dng